Zhen-Gang Yuan (Zhengang Yuan)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Top Venues

Nature communications

Science translational medicine

The Journal of international medical research

This page only lists publications with an associated author ORCID identifier.

Publications

Tian-Mei Zeng, Guang Yang, Cheng Lou, Wei Wei, Chen-Jie Tao, Xi-Yun Chen, Qin Han, Zhuo Cheng, Pei-Pei Shang, Yu-Long Dong, He-Ming Xu, Lie-Ping Guo, Dong-Sheng Chen, Yun-Jie Song, Chuang Qi, Wang-Long Deng, Zhen-Gang Yuan
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer. Nature communications 14 (1) (2023)
Tian-Mei Zeng, Guang Yang, Cheng Lou, Wei Wei, Chen-Jie Tao, Xi-Yun Chen, Qin Han, Zhuo Cheng, Pei-Pei Shang, Yu-Long Dong, He-Ming Xu, Lie-Ping Guo, Dong-Sheng Chen, Yun-Jie Song, Chuang Qi, Wang-Long Deng, Zhen-Gang Yuan
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer. Nature communications 14 (1) (2023)
Tian-Yi Jiang, Xiao-Wen Cui, Tian-Mei Zeng, Yu-Fei Pan, Yun-Kai Lin, Xiao-Fan Feng, Ye-Xiong Tan, Zhen-Gang Yuan, Li-Wei Dong, Hong-Yang Wang
PTEN deficiency facilitates gemcitabine efficacy in cancer by modulating the phosphorylation of PP2Ac and DCK. Science translational medicine 15 (704) (2023)
Tian-Mei Zeng, Guang Yang, Cheng Lou, Wei Wei, Chen-Jie Tao, Xi-Yun Chen, Qin Han, Zhuo Cheng, Pei-Pei Shang, Yu-Long Dong, He-Ming Xu, Lie-Ping Guo, Dong-Sheng Chen, Yun-Jie Song, Chuang Qi, Wang-Long Deng, Zhen-Gang Yuan
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer. Nature communications 14 (1) (2023)
Peipei Shang, Cheng Lou, Lei Yin, Chenjie Tao, Yulong Dong, Guang Yang, Zhen-Gang Yuan
Advanced renal pelvis carcinoma patient with an ERBB2 insertion mutation: a case report. The Journal of international medical research 51 (11) (2023)
Tian-Mei Zeng, Guang Yang, Cheng Lou, Wei Wei, Chen-Jie Tao, Xi-Yun Chen, Qin Han, Zhuo Cheng, Pei-Pei Shang, Yu-Long Dong, He-Ming Xu, Lie-Ping Guo, Dong-Sheng Chen, Yun-Jie Song, Chuang Qi, Wang-Long Deng, Zhen-Gang Yuan
Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer. Nature communications 14 (1) (2023)